Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.

Esslimani-Sahla, Majida

Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2004 - 5769-76 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-04-0389 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma, Ductal, Breast--drug therapy
Carcinoma, Lobular--drug therapy
Cell Proliferation
Drug Resistance, Neoplasm
Estrogen Receptor beta--metabolism
Female
Humans
Immunoenzyme Techniques
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local--drug therapy
Predictive Value of Tests
Retrospective Studies
Survival Rate
Tamoxifen--therapeutic use